Characteristics of cancer patients with VTE, n = 44
Characteristic . | Value . |
---|---|
Age at study entry, y [median (IQR)] | 62 (48-66) |
Sex, n (%) | |
Female | 20 (45.5) |
Male | 24 (54.5) |
Site of thrombotic event, n (%) | |
Isolated deep venous thrombosis (DVT) | 19 (45.5) |
Isolated pulmonary embolism (PE) | 18 (38.6) |
Combined DVT and PE | 2 (4.5) |
Thrombosis of the portal vein | 1 (2.3) |
Sinus vein thrombosis | 1 (2.3) |
Inferior vein cava thrombosis | 1 (2.3) |
Combined DVT and thrombosis of the portal vein | 1 (2.3) |
Combined brachial vein thrombosis and PE | 1 (2.3) |
Classification of tumor, n (%) | |
Localized | 10 (22.7) |
Distant metastasis | 17 (38.6) |
Not classifiable (brain tumors and hematologic malignancies) | 17 (38.6) |
Classification unclear | 0 (0) |
Site of cancer, n (%) | |
Breast | 2 (4.5) |
Lung | 3 (6.8) |
Upper gastrointestinal | 5 (11.4) |
Colorectal | 8 (18.2) |
Pancreas | 6 (13.6) |
Kidney | 0 (0) |
Prostate | 0 (0) |
Brain | 13 (29.5) |
Lymphoma | 3 (6.8) |
Multiple myeloma | 1 (2.3) |
Others | 3 (6.8) |
Characteristic . | Value . |
---|---|
Age at study entry, y [median (IQR)] | 62 (48-66) |
Sex, n (%) | |
Female | 20 (45.5) |
Male | 24 (54.5) |
Site of thrombotic event, n (%) | |
Isolated deep venous thrombosis (DVT) | 19 (45.5) |
Isolated pulmonary embolism (PE) | 18 (38.6) |
Combined DVT and PE | 2 (4.5) |
Thrombosis of the portal vein | 1 (2.3) |
Sinus vein thrombosis | 1 (2.3) |
Inferior vein cava thrombosis | 1 (2.3) |
Combined DVT and thrombosis of the portal vein | 1 (2.3) |
Combined brachial vein thrombosis and PE | 1 (2.3) |
Classification of tumor, n (%) | |
Localized | 10 (22.7) |
Distant metastasis | 17 (38.6) |
Not classifiable (brain tumors and hematologic malignancies) | 17 (38.6) |
Classification unclear | 0 (0) |
Site of cancer, n (%) | |
Breast | 2 (4.5) |
Lung | 3 (6.8) |
Upper gastrointestinal | 5 (11.4) |
Colorectal | 8 (18.2) |
Pancreas | 6 (13.6) |
Kidney | 0 (0) |
Prostate | 0 (0) |
Brain | 13 (29.5) |
Lymphoma | 3 (6.8) |
Multiple myeloma | 1 (2.3) |
Others | 3 (6.8) |